Tang Wan-yee, Ho Shuk-mei
Department of Environmental Health, College of Medicine, University of Cincinnati, Cincinnati, OH, USA.
Rev Endocr Metab Disord. 2007 Jun;8(2):173-82. doi: 10.1007/s11154-007-9042-4.
The traditional view that gene and environment interactions control disease susceptibility can now be expanded to include epigenetic reprogramming as a key determinant of origins of human disease. Currently, epigenetics is defined as heritable changes in gene expression that do not alter DNA sequence but are mitotically and transgenerationally inheritable. Epigenetic reprogramming is the process by which an organism's genotype interacts with the environment to produce its phenotype and provides a framework for explaining individual variations and the uniqueness of cells, tissues, or organs despite identical genetic information. The main epigenetic mediators are histone modification, DNA methylation, and non-coding RNAs. They regulate crucial cellular functions such as genome stability, X-chromosome inactivation, gene imprinting, and reprogramming of non-imprinting genes, and work on developmental plasticity such that exposures to endogenous or exogenous factors during critical periods permanently alter the structure or function of specific organ systems. Developmental epigenetics is believed to establish "adaptive" phenotypes to meet the demands of the later-life environment. Resulting phenotypes that match predicted later-life demands will promote health, while a high degree of mismatch will impede adaptability to later-life challenges and elevate disease risk. The rapid introduction of synthetic chemicals, medical interventions, environmental pollutants, and lifestyle choices, may result in conflict with the programmed adaptive changes made during early development, and explain the alarming increases in some diseases. The recent identification of a significant number of epigenetically regulated genes in various model systems has prepared the field to take on the challenge of characterizing distinct epigenomes related to various diseases. Improvements in human health could then be redirected from curative care to personalized, preventive medicine based, in part, on epigenetic markings etched in the "margins" of one's genetic make-up.
传统观点认为基因与环境的相互作用控制着疾病易感性,现在这一观点可进一步扩展,将表观遗传重编程纳入其中,因为它是人类疾病起源的关键决定因素。目前,表观遗传学被定义为基因表达的可遗传变化,这种变化不会改变DNA序列,但可在有丝分裂过程中及跨代遗传。表观遗传重编程是生物体基因型与环境相互作用以产生其表型的过程,它为解释个体差异以及细胞、组织或器官的独特性提供了一个框架,尽管它们具有相同的遗传信息。主要的表观遗传调节因子是组蛋白修饰、DNA甲基化和非编码RNA。它们调节关键的细胞功能,如基因组稳定性、X染色体失活、基因印记以及非印记基因的重编程,并作用于发育可塑性,使得在关键时期暴露于内源性或外源性因素会永久性改变特定器官系统的结构或功能。发育表观遗传学被认为会建立“适应性”表型以满足后期生活环境的需求。与预测的后期生活需求相匹配的最终表型将促进健康,而高度不匹配则会阻碍对后期生活挑战的适应能力并增加疾病风险。合成化学物质、医学干预、环境污染物和生活方式选择的迅速引入,可能与早期发育过程中设定的适应性变化产生冲突,并解释了某些疾病令人担忧的增加情况。最近在各种模型系统中发现了大量受表观遗传调控的基因,这使得该领域有能力应对表征与各种疾病相关的独特表观基因组的挑战。人类健康的改善随后可从治疗性护理转向个性化的预防医学,部分基于铭刻在个人基因组成“边缘”的表观遗传标记。